Latest Perspective in Ovarian Cancer Care

Register Now to Learn More about Advanced Ovarian Cancer.

Panelists

  1. Warner K. Huh, MD

    Warner K. Huh, MD

    Chairperson of Obstetrics and Gynecology
    University of Alabama at Birmingham (UAB)

    Moderator and Chair

    Go to last slideGo to next slide
  2. Dan S. Veljovich, MD

    Dan S. Veljovich, MD

    Gynecologic Oncologist
    Swedish Cancer Institute
    Seattle

    Go to last slideGo to next slide
  3. Nicole Tasker, RN, MSN, FNP-BC

    Nicole Tasker, RN, MSN, FNP-BC

    Gynecologic Oncology
    Advanced Practice Nurse
    Northwestern Medicine
    Chicago

    Go to last slideGo to next slide
  4. Sharyn N.Lewin, MD, FACS, FACOG

    Sharyn N.Lewin, MD, FACS, FACOG

    Director, Division of Gynecologic Oncology
    Holy Name Medical Center
    New Jersey

    Go to last slideGo to next slide
  5. Allison Guyton, PharmD, BCOP, BCPS

    Allison Guyton, PharmD, BCOP, BCPS

    Oncology Pharmacy Specialist
    Huntsville Hospital
    Alabama

    Go to last slideGo to next slide
  6. Go to last slideGo to next slide

All healthcare professionals have been compensated by AstraZeneca for their participation.

Agenda Topics

arrows dark
The closer we look, further we'll go

Highligting the current state of ovarian cancer and current treatments to understand the challenges faced by those living with ovarian cancer.

arrows dark
What if the treatment were as unique as the tumor?

Understanding the history of where we've been with ovarian cancer, and what's in store for the future and your role in it.

arrows dark
To test is to know what to target

Exploring the new advances in genomic profiling of ovarian cancer tumors and optimizing treatment outcomesfor patients.

arrows dark
Using the journey to define the destination

Applying personalized treatments in practice, and the impacts these can have on those with ovarian cancer

Additional Video Resources

Latest Perspectives in Ovarian Cancer Care - Highlights
Embedding Biomarker Testing Protocols
Advancements in Ovarian Cancer Management and PARP Inhibitors
Diagnostics and Advances in Ovarian Cancer Management
The Biomarker Driven Nature of Ovarian Cancer
Integrated Care and Personalized Treatment
Enhancing Communication Around Personalized Medicine
Understanding the Importance of Integrated Care
Integrating Germline and Somatic Testing
Maintenance Therapy in Ovarian Cancer

Exclusive post-event coverage today |
FREE DOWNLOAD

Onclive® is now offering exclusive access to the materials presented in this broadcast. Get free access to the presentation, key takeaways, and a whitepaper, covering theLatest Perspectives in Ovarian Cancer Care

downloadable content

For US Health Professionals Only.
This iPub® is sponsered by astraZeneca.
2021 AstraZeneca.All rights reserved.
US-57912 Last Updated 10/21

iPub logo